Molecular Formula | C26H37ClN2O4 |
Molar Mass | 477.04 |
Melting Point | softens at 50°C, 155-160°C dec. |
Flash Point | 9℃ |
Solubility | H2O: >10mg/mL |
Appearance | solid |
Color | white |
Storage Condition | desiccated |
Stability | Hygroscopic |
In vitro study | Norverapamil hydrochloride ((±)-Norverapamil hydrochloride) is similarly effective as verapamil at inhibiting isoniazid and rifampicin tolerance and killing of intracellular M. tuberculosis in the absence of other drugs. norverapamil, also inhibits macrophage-induced tolerance and achieves similar serum levels to verapamil. Verapamil and its major metabolite norverapamil were identified to be both mechanism-based inhibitors and substrates of CYP3A and reported to have non-linear pharmacokinetics in clinic. |
UN IDs | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.096 ml | 10.481 ml | 20.963 ml |
5 mM | 0.419 ml | 2.096 ml | 4.193 ml |
10 mM | 0.21 ml | 1.048 ml | 2.096 ml |
5 mM | 0.042 ml | 0.21 ml | 0.419 ml |